{
    "symbol": "CTIC",
    "quarter": 4,
    "year": 2022,
    "date": "2023-03-06 13:57:05",
    "content": " We completed a strong sales performance with a 16% quarterly sales increase in Q4 and continued to show strong launch momentum in the quarter across several key metrics, including consistent growth in new patient starts, substantial increase in the number of active patients on VONJO, significant growth in new MF prescribers and accounts, a strong and expanding refill order rate and increased awareness and interest in VONJO's hematologic safety profile for anemia and thrombocytopenia. Your line is now open. Your line is now open. Your line is now open. Your line is now open. Your line is now open."
}